Format

Send to

Choose Destination
Curr HIV/AIDS Rep. 2017 Jun;14(3):83-92. doi: 10.1007/s11904-017-0349-9.

Monitoring HIV-Associated Neurocognitive Disorder Using Screenings: a Critical Review Including Guidelines for Clinical and Research Use.

Kamminga J1,2, Lal L3,4, Wright EJ3,4,5, Bloch M6,7, Brew BJ6,8,9, Cysique LA10,11,12,13.

Author information

1
Neuroscience Research Australia, 139 Barker Street, Randwick, NSW, 2031, Australia.
2
Ongoing and Extended Care Services, Hunter New England Local Health District, Armidale Community Health, Armidale, NSW, 2350, Australia.
3
The Burnet Institute, Melbourne, VIC, 3004, Australia.
4
The Alfred Hospital, Melbourne, VIC, 3004, Australia.
5
Monash University, Clayton, VIC, 3800, Australia.
6
Faculty of Medicine, The University of New South Wales, Sydney, NSW, 2052, Australia.
7
Holdsworth House Medical Practice, Sydney, NSW, 2000, Australia.
8
St. Vincent's Hospital Applied Medical Research Center, The Peter Duncan Neuroscience Unit, Darlinghurst, NSW, 2010, Australia.
9
Neurology and HIV Departments, St. Vincent's Hospital, Darlinghurst, NSW, 2010, Australia.
10
Neuroscience Research Australia, 139 Barker Street, Randwick, NSW, 2031, Australia. lcysique@unsw.edu.au.
11
Faculty of Medicine, The University of New South Wales, Sydney, NSW, 2052, Australia. lcysique@unsw.edu.au.
12
St. Vincent's Hospital Applied Medical Research Center, The Peter Duncan Neuroscience Unit, Darlinghurst, NSW, 2010, Australia. lcysique@unsw.edu.au.
13
Neurology and HIV Departments, St. Vincent's Hospital, Darlinghurst, NSW, 2010, Australia. lcysique@unsw.edu.au.

Abstract

Screening tools to identify HIV-associated neurocognitive disorder (HAND) are primarily devised to detect cognitive impairment on a single occasion. With the chronicity of HIV infection and the risk of HAND developing or progressing despite viral control, it may be pertinent to repeat HAND screening at more than one time point. Despite this, there are limited data on longitudinal use of such screening tools, particularly with regard to the role of practice effects. Additionally, no guidelines currently exist on the timeframe between testing intervals, or recommendation of the magnitude of baseline impairment that warrants follow-up testing. The aim of the current paper was to review existing evidence for longitudinal validity of HAND screening tools. Only those HAND screening tools previously found to have high cross-sectional criterion validity were included. Preliminary recommendations for clinical use and future research are proposed including in international settings.

KEYWORDS:

Aids; Cognitive screen; Computerized screen; HIV; HIV dementia scale; Hand; International settings; Longitudinal studies; Neuropsychology; Reliability

PMID:
28284004
DOI:
10.1007/s11904-017-0349-9
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center